Motif Bio plc Warrants to Purchase ADRs
MTFBW
MTFBW was delisted on the 16th of December, 2019.
3 hedge funds and large institutions have $934K invested in Motif Bio plc Warrants to Purchase ADRs in 2018 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 3 → 3 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
47% less capital invested
Capital invested by funds: $1.76M → $934K (-$824K)
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Invesco
Atlanta,
Georgia
| $791K | – | – | – |
|
|
SGCM
2
Sand Grove Capital Management
London,
United Kingdom
| $141K | – | – | – |
|
3
UBS Group
Zurich,
Switzerland
| $2K | – | – | – |
|
MTFBW Hedge Fund Activity: Q4 2018 in Review
3 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Motif Bio plc Warrants to Purchase ADRs (MTFBW) for Q4 2018, worth a combined $934K — down 47% from $1.76M a quarter earlier.
Fund positioning in MTFBW was balanced in Q4 2018: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.
- 3 institutional investors held Motif Bio plc Warrants to Purchase ADRs (MTFBW) as of Q4 2018, unchanged from Q3 2018.
- Funds reported $934K of Motif Bio plc Warrants to Purchase ADRs stock for Q4 2018, down 47% quarter-over-quarter.
- 0 funds opened new Motif Bio plc Warrants to Purchase ADRs positions in Q4 2018 and 0 closed out.
Based on aggregated 13F filings for Q4 2018.